General Information of Drug (ID: DMVMQ1L)

Drug Name
Nafronyl Drug Info
Synonyms
Nafronyl oxalate; 3200-06-4; Naftidrofuryl oxalate; Nafronyl oxalate salt; 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate; Naftidrofuryl (oxalate); Dusodril; Dubimax; Praxilene; Iridus; LS-121; EU-1806; DSSTox_RID_80935; DSSTox_CID_25533; DSSTox_GSID_45533; naftidrofuryl hydrogen oxalate; CHEMBL1439099; alpha-[1-Naphthylmethyl]-2-tetrahydrofuranpropionic acid diethylaminoethyl ester; SMR000539007; Nafronyl oxalate salt, analytical standard; CAS-3200-06-4; NSC225233; LS 121
Indication
Disease Entry ICD 11 Status REF
Cerebrovascular ischaemia 8B1Z Approved [1]
Cross-matching ID
PubChem CID
4417
ChEBI ID
CHEBI:91817
CAS Number
CAS 31329-57-4
TTD Drug ID
DMVMQ1L
INTEDE Drug ID
DR2473

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug(s) Targeting 5-HT receptor (5HTR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metergolin DMJFP6G Hyperprolactinaemia 5A60.1 Approved [3]
Paliperidone DM7NPJS Psychotic disorder 6A20-6A25 Approved [1]
Ramosetron DMH7GN8 Diarrhea-predominant irritable bowel syndrome DD91.01 Approved [3]
Pizotyline DMV74ZH Headache 8A80-8A84 Approved [1]
Tandospirone DMPHWU6 Anxiety disorder 6B00-6B0Z Approved [3]
ITI-007 DMUQ1DO Depression 6A70-6A7Z Phase 3 [4]
Fenfluramine DM0762O Dravet syndrome 8A61.11 Phase 3 [5]
MIN-117 DMSLIW6 Major depressive disorder 6A70.3 Phase 2 [4]
Lu-AA34893 DM2ZUXK Anxiety disorder 6B00-6B0Z Phase 2 [6]
SEP--4199 DMA12HB Bipolar disorder 6A60 Phase 2 [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [2]
Vidarabine DM0N85H Hepatosplenic T-cell lymphoma Approved [2]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [8]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [9]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [10]
Etidronic acid DM1XHYJ Bone Paget disease Approved [2]
Tiaprofenic acid DM23D7J Osteoarthritis FA00-FA05 Approved [2]
Bromperidol DM24XYQ Schizophrenia 6A20 Approved [2]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [11]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [12]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
5-HT receptor (5HTR) TT85JO3 NOUNIPROTAC Modulator [1]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Nuclear receptor subfamily 1 group I member 2 (NR1I2) OTC5U0N5 NR1I2_HUMAN Gene/Protein Processing [2]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
3 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
6 Encyclopedia of Psychopharmacology. Ian Stolerman. 2010. Page(105).
7 ClinicalTrials.gov (NCT03543410) A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression. U.S. National Institutes of Health.
8 Induction of PXR-mediated metabolism by beta-carotene. Biochim Biophys Acta. 2005 May 30;1740(2):162-9. doi: 10.1016/j.bbadis.2004.11.013. Epub 2004 Dec 8.
9 Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol. 2005 Dec 1;209(2):123-33. doi: 10.1016/j.taap.2005.03.015.
10 Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening. Drug Metab Dispos. 2011 Feb;39(2):337-44. doi: 10.1124/dmd.110.035808. Epub 2010 Nov 10.
11 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
12 Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett. 2017 Jan 4;265:86-96.